{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-058085","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.858013+00:00","generated_at":"2026-05-31T23:49:55.127389+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Estrella Immunopharma merges wholly-owned sub Estrella Biopharma into parent","bullets":["Merger effective June 30, 2024; Estrella Biopharma ceased to exist, Estrella Immunopharma survives.","No changes to management, board, ownership, charter, or bylaws as a result of the merger.","Merger approved by unanimous written consent of board; intended to simplify corporate structure and streamline financial reporting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-058085","json":"https://secwatch.observer/filing/0001213900-24-058085.json","markdown":"https://secwatch.observer/filing/0001213900-24-058085.md","text":"https://secwatch.observer/filing/0001213900-24-058085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024058085/0001213900-24-058085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024058085/ea0208757-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:49:55.127389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}